Abstract
Squamous cell carcinoma of anal canal (SCCA) and its precursor lesions are increasing in prevalence for the diffusion of human papillomavirus infection. The treatment of the cancer of the anal canal represents a model for the application of organ sparing, combined modality therapy for curative treatment. Squamous cell carcinoma of anal canal was originally a surgically treated disease that required Abdominoperineal Resection (APR), approximately two thirds of patients are now cured with a combination of chemotherapy and radiation with sphincter preservation. This article reviews randomized trials and recent studies on chemoradiation for anal cancer.
Keywords: Anal cancer, radiotherapy, chemotherapy
Current Drug Therapy
Title: The Association of Chemotherapy and Radiotherapy in Squamous Cell Carcinoma of Anal Canal
Volume: 5 Issue: 3
Author(s): Francesca Valvo, Barbara Avuzzi and Federico Bozzetti
Affiliation:
Keywords: Anal cancer, radiotherapy, chemotherapy
Abstract: Squamous cell carcinoma of anal canal (SCCA) and its precursor lesions are increasing in prevalence for the diffusion of human papillomavirus infection. The treatment of the cancer of the anal canal represents a model for the application of organ sparing, combined modality therapy for curative treatment. Squamous cell carcinoma of anal canal was originally a surgically treated disease that required Abdominoperineal Resection (APR), approximately two thirds of patients are now cured with a combination of chemotherapy and radiation with sphincter preservation. This article reviews randomized trials and recent studies on chemoradiation for anal cancer.
Export Options
About this article
Cite this article as:
Valvo Francesca, Avuzzi Barbara and Bozzetti Federico, The Association of Chemotherapy and Radiotherapy in Squamous Cell Carcinoma of Anal Canal, Current Drug Therapy 2010; 5 (3) . https://dx.doi.org/10.2174/157488510791561093
DOI https://dx.doi.org/10.2174/157488510791561093 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High Throughput Bioassays Using Nanoparticles
Combinatorial Chemistry & High Throughput Screening Artificial Hematopoietic Stem Cell Niche: Bioscaffolds to Microfluidics to Mathematical Simulations
Current Topics in Medicinal Chemistry Pulmonary Embolism Response Team (PERT) - A New Paradigm for the Treatment of Pulmonary Embolism
Current Pharmaceutical Design Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance
Current Medicinal Chemistry Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Third Generation Radiopharmaceuticals for Imaging and Targeted Therapy
Current Pharmaceutical Analysis Efficacy and Toxicological Studies of Cremophor EL Free Alternative Paclitaxel Formulation
Current Drug Safety Deubiquitinating Enzymes are IN(Trinsic to Proteasome Function)
Current Protein & Peptide Science PCA as a Practical Indicator of OPLS-DA Model Reliability
Current Metabolomics Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry In Silico Classification and Prediction of VIP Derivatives as VPAC1/ VPAC2 Receptor Agonists/Antagonists
Combinatorial Chemistry & High Throughput Screening An Overall Picture of Chemokine Receptors: Basic Research and Drug Development
Current Pharmaceutical Design Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design Optical Chemical Biosensors for High Throughput Screening of Drugs
Combinatorial Chemistry & High Throughput Screening Synthesis of New 3-heteroaryl-2-phenylquinolines and their Pharmacological Activity as Antimicrobial Agents
Letters in Organic Chemistry Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Prepare and Assessment of a New Purity Certified Reference Material of Quercetin
Current Analytical Chemistry Evolution of the Scientific Literature of Cytochrome P450 from 1977 to 2008
Current Drug Metabolism Multilanthanide Systems for Medical Imaging Applications
Recent Patents on Nanomedicine Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe
Current Drug Metabolism